Wellington Management Group’s RxSight RXST Stock Holding History

Wellington Management Group’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-727,952	Closed	-$9.46M	–	2087
2025 Q2	$9.46M	Buy	+727,952	New	+$10.9M	﹤0.01%	1223

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group's RXST Position: Q3 2025 in Review

Wellington Management Group sold out of RxSight (RXST) in Q3 2025, closing a stake of 727,952 shares — an estimated $9.46M sold.

Wellington Management Group first reported a position in RXST in Q2 2025 and held it in 1 quarter. The position peaked at $9.46M in Q2 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

Wellington Management Group reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
Wellington Management Group sold 727,952 RxSight shares in Q3 2025, an estimated $9.46M.
Wellington Management Group first reported a position in RxSight in Q2 2025 and held it in 1 quarter.
Wellington Management Group's RxSight position peaked at $9.46M in Q2 2025.
160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.